, significant challenges remain, including the variability in SVF composition, optimal delivery
methods, timing
Mustafin, R.N.,
Bermisheva, M.A.,
Karunas, A.S.,
Akhmetshin, A.A.,
Monakhova, A.S.,
Khusnutdinova, E.K. (2025) of the genetic causes of NF1 can become the basis for prenatal diagnosis and the use of new
methods of treating
Sangeet, Ghai,,
Ni, Tiffany T.,
Pavlovich, Christian P.,
Futterer, Jurgen J.,
Schade, George R.,
Sanchez-Salas, Rafael,
Cornud, Francois,
Eggener, Scott,
Feller, John F.,
George, Arvin K.,
Villers, Arnauld,
de la Rosette, Jean (2025) ), and histotripsy.
Methods: A comprehensive literature search was conducted to identify studies and clinical trials
Timasheva, Yanina,
Kochetova, Olga,
Balkhiyarova, Zhanna,
Korytina, Gulnaz,
Prokopenko, Inga,
Nouwen, Arie (2025) , neurotransmitters, and β-cell function, to develop a prognostic tool for MetS risk.
Methods: We genotyped 40 genetic